Literature DB >> 29218669

Laparoscopy as a useful selection tool for patients with prior surgery and peritoneal metastases suitable for multimodality treatment strategies.

Philipp von Breitenbuch1,2, Thomas Boerner3, Tonia Jeiter4, Pompiliu Piso4, Hans J Schlitt3.   

Abstract

BACKGROUND: Complete macroscopic cytoreduction in patients with peritoneal carcinomatosis (PC) is the basic requirement for long-term survival. Diagnostic laparoscopy (DL) can be difficult and of limited clinical value secondary to postoperative or tumor-induced adhesions. The aim of this study was to evaluate the role of DL in patients with prior surgery and PC.
METHODS: The database of the surgical department of the University Medical Center of Regensburg was reviewed (9/2010-10/2014) selecting for DL in patients with PC. The operative report had a standardized format allowing for the determination of the extent of the intra-abdominal visible area and the extent of tumor on the surface of the small intestine. For the classification we used our own developed score.
RESULTS: DL was performed in 102 patients. The complete abdominal cavity was evaluable in 48%. At least two quadrants and the largest part of the small intestine could be assessed in 70%. 37% of the patients had massive tumor manifestation on the small intestine or its mesentery. PCI (Peritoneal Cancer Index) could not be calculated in 71% of the patients due to incomplete visualization of the abdominal cavity and/or multiple tumor manifestations on the small intestine. 54% of patients were classified as non-resectable and 85% who seemed suitable for cytoreductive surgery underwent a CCR-0 resection and HIPEC.
CONCLUSIONS: In spite of prior surgery and PC, DL is frequently possible and a useful tool to define the extent of tumor spread. Lots of patients can be prevented from needless open laparotomy. The extent of tumor involvement of the small intestine seems to be more relevant than calculation of the PCI to determine the potential for complete resection. Therefore, in the presence of adhesions, inspection of the complete abdominal cavity does not offer added clinical benefit and further adhesiolysis can be avoided.

Entities:  

Keywords:  Laparoscopy; Operability; Peritoneal carcinomatosis

Mesh:

Year:  2017        PMID: 29218669     DOI: 10.1007/s00464-017-5923-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  21 in total

1.  Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study.

Authors:  J Spiliotis; E Halkia; E Lianos; N Kalantzi; A Grivas; E Efstathiou; S Giassas
Journal:  Ann Surg Oncol       Date:  2014-11-13       Impact factor: 5.344

2.  Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study.

Authors:  J Esquivel; T C Chua; A Stojadinovic; J Torres Melero; E A Levine; M Gutman; R Howard; P Piso; A Nissan; A Gomez-Portilla; L Gonzalez-Bayon; S Gonzalez-Moreno; P Shen; J H Stewart; P H Sugarbaker; R M Barone; R Hoefer; D L Morris; A Sardi; R P Sticca
Journal:  J Surg Oncol       Date:  2010-11-01       Impact factor: 3.454

3.  Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients.

Authors:  N Bakrin; J M Bereder; E Decullier; J M Classe; S Msika; G Lorimier; K Abboud; P Meeus; G Ferron; F Quenet; F Marchal; S Gouy; P Morice; C Pomel; M Pocard; F Guyon; J Porcheron; O Glehen
Journal:  Eur J Surg Oncol       Date:  2013-10-17       Impact factor: 4.424

4.  American Society of Peritoneal Surface Malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer.

Authors:  Jesus Esquivel; Pompiliu Piso; Vic Verwaal; Thomas Bachleitner-Hofmann; Olivier Glehen; Santiago González-Moreno; Marcello Deraco; Joerg Pelz; Richard Alexander; Gabriel Glockzin
Journal:  J Surg Oncol       Date:  2014-07-08       Impact factor: 3.454

5.  The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy.

Authors:  C Pomel; T-L Appleyard; S Gouy; R Rouzier; D Elias
Journal:  Eur J Surg Oncol       Date:  2005-06       Impact factor: 4.424

6.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

7.  Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis.

Authors:  Ju-Li Koh; Tristan D Yan; Derek Glenn; David L Morris
Journal:  Ann Surg Oncol       Date:  2008-12-03       Impact factor: 5.344

8.  Evaluation of computed tomography in patients with peritoneal carcinomatosis.

Authors:  P Jacquet; J S Jelinek; M A Steves; P H Sugarbaker
Journal:  Cancer       Date:  1993-09-01       Impact factor: 6.860

9.  Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

Authors:  Dominique Elias; Jérémie H Lefevre; Julie Chevalier; Antoine Brouquet; Frédéric Marchal; Jean-Marc Classe; Gwenaël Ferron; Jean-Marc Guilloit; Pierre Meeus; Diane Goéré; Julia Bonastre
Journal:  J Clin Oncol       Date:  2008-12-22       Impact factor: 44.544

Review 10.  The intraoperative staging systems in the management of peritoneal surface malignancy.

Authors:  A Gomez Portilla; Kusamura Shigeki; Baratti Dario; Deraco Marcello
Journal:  J Surg Oncol       Date:  2008-09-15       Impact factor: 3.454

View more
  5 in total

Review 1.  [Oligometastases in gastric and esophageal cancer : Current clinical trials and surgical concepts].

Authors:  S Beckert; A Königsrainer
Journal:  Chirurg       Date:  2018-07       Impact factor: 0.955

2.  Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience.

Authors:  Fabio Carboni; Orietta Federici; Isabella Sperduti; Settimio Zazza; Domenico Sergi; Francesco Corona; Mario Valle
Journal:  Cancers (Basel)       Date:  2021-01-29       Impact factor: 6.639

3.  Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer.

Authors:  F S Verheij; C Bakkers; W J van Eden; A G J Aalbers; S W Nienhuijs; K Jóźwiak; I H J T de Hingh; N F M Kok
Journal:  BJS Open       Date:  2020-06-23

Review 4.  Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details.

Authors:  Thomas Boerner; Pompiliu Piso
Journal:  J Clin Med       Date:  2021-11-12       Impact factor: 4.241

5.  Role of diagnostic laparoscopy in patients with suspicion of colorectal peritoneal metastases to evaluate suitability for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Authors:  J E K R Hentzen; W Y van der Plas; R D N Constansia; L B Been; F J H Hoogwater; R J van Ginkel; G M van Dam; P H J Hemmer; S Kruijff
Journal:  BJS Open       Date:  2019-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.